Experience of a Single Center in Treating Multiple Manifestations of Tuberous Sclerosis Complex with Everolimus
Purpose The aim of this study was to evaluate the efficacy and tolerability of everolimus, an oral mammalian target of rapamycin (mTOR) inhibitor, for the treatment of tuberous sclerosis complex (TSC) manifestations. Methods A retrospective analysis was conducted using an in-house research database...
Main Authors: | Hyunji Ahn, Mi-Sun Yum, Han Na Jang, Cheryn Song, Tae-Sung Ko |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Child Neurology Society
2019-12-01
|
Series: | Annals of Child Neurology |
Subjects: | |
Online Access: | http://www.annchildneurol.org/upload/pdf/acn-2019-00206.pdf |
Similar Items
-
Effect and Complications of Everolimus Use for Giant Cardiac Rhabdomyomas with Neonatal Tuberous Sclerosis
by: Yuka Shibata, et al.
Published: (2019-07-01) -
Varied manifestations of tuberous sclerosis
by: Nikhil Gupta, et al.
Published: (2015-01-01) -
Everolimus Reduces the Size of Tuberous Sclerosis Complex-Related Huge Renal Angiomyolipomas Exceeding 20 cm in the Longest Diameter
by: Naoya Toriu, et al.
Published: (2018-05-01) -
Symptomatic improvement using everolimus in infants with cardiac rhabdomyoma
by: Bhargavi Dhulipudi, et al.
Published: (2019-01-01) -
Efficacy of Everolimus Low-Dose Treatment for Cardiac Rhabdomyomas in Neonatal Tuberous Sclerosis: Case Report and Literature Review
by: Luisa Federica Nespoli, et al.
Published: (2021-03-01)